Cargando…
Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology
BACKGROUND: Assessment of treatment effects in clinical trials requires valid information on treatment adherence, adverse events and symptoms. Paper‐based diaries are often inconvenient and have limited reliability, particularly for outpatient trials. OBJECTIVES: To investigate the utility of an ele...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064941/ https://www.ncbi.nlm.nih.gov/pubmed/31419338 http://dx.doi.org/10.1111/jdv.15872 |
_version_ | 1783504964702699520 |
---|---|
author | Rijsbergen, M. Niemeyer‐van der Kolk, T. Rijneveld, R. Pinckaers, J.H.F.M. Meshcheriakov, I. Bouwes Bavinck, J.N. van Doorn, M.B.A. Hogendoorn, G. Feiss, G. Cohen, A.F. Burggraaf, J. van Poelgeest, M.I.E. Rissmann, R. |
author_facet | Rijsbergen, M. Niemeyer‐van der Kolk, T. Rijneveld, R. Pinckaers, J.H.F.M. Meshcheriakov, I. Bouwes Bavinck, J.N. van Doorn, M.B.A. Hogendoorn, G. Feiss, G. Cohen, A.F. Burggraaf, J. van Poelgeest, M.I.E. Rissmann, R. |
author_sort | Rijsbergen, M. |
collection | PubMed |
description | BACKGROUND: Assessment of treatment effects in clinical trials requires valid information on treatment adherence, adverse events and symptoms. Paper‐based diaries are often inconvenient and have limited reliability, particularly for outpatient trials. OBJECTIVES: To investigate the utility of an electronic diary (e‐diary) application for patients with skin diseases in outpatient clinical trials. METHODS: An e‐diary application was developed and technically validated. Treatment adherence was defined as topical administration by the patient, and patient‐reported outcomes, i.e. pain and itch, were evaluated by the e‐diary in six clinical trials on newly tested topical drugs. Additionally, the proportion of patients capturing the applied topical drug by camera and filling in the pain and itch scores was defined as e‐diary adherence, and patients’ perception of usefulness and acceptability of the e‐diary were evaluated. RESULTS: Treatment adherence rates of the included 256 patients were high (median 98%, range 97–99%). E‐diary adherence was also high with a median of 93% (range 87–97%) for capturing the applied drug by camera, and 89% (range 87–96%) and 94% (range 87–96%) for entering respectively the itch and pain score. Daily symptom scores provided good insights into the disease burden, and patients rated the e‐diary as good to excellent with respect to user acceptability. CONCLUSIONS: The results suggest that the e‐diary is an excellent way to ensure proper treatment administration, indicated by both the high user acceptability scores and high treatment adherence. Moreover, the e‐diary may also be valuable for frequent and reliable monitoring of patient‐reported outcomes in daily clinical practice. |
format | Online Article Text |
id | pubmed-7064941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70649412020-03-16 Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology Rijsbergen, M. Niemeyer‐van der Kolk, T. Rijneveld, R. Pinckaers, J.H.F.M. Meshcheriakov, I. Bouwes Bavinck, J.N. van Doorn, M.B.A. Hogendoorn, G. Feiss, G. Cohen, A.F. Burggraaf, J. van Poelgeest, M.I.E. Rissmann, R. J Eur Acad Dermatol Venereol Teledermatology BACKGROUND: Assessment of treatment effects in clinical trials requires valid information on treatment adherence, adverse events and symptoms. Paper‐based diaries are often inconvenient and have limited reliability, particularly for outpatient trials. OBJECTIVES: To investigate the utility of an electronic diary (e‐diary) application for patients with skin diseases in outpatient clinical trials. METHODS: An e‐diary application was developed and technically validated. Treatment adherence was defined as topical administration by the patient, and patient‐reported outcomes, i.e. pain and itch, were evaluated by the e‐diary in six clinical trials on newly tested topical drugs. Additionally, the proportion of patients capturing the applied topical drug by camera and filling in the pain and itch scores was defined as e‐diary adherence, and patients’ perception of usefulness and acceptability of the e‐diary were evaluated. RESULTS: Treatment adherence rates of the included 256 patients were high (median 98%, range 97–99%). E‐diary adherence was also high with a median of 93% (range 87–97%) for capturing the applied drug by camera, and 89% (range 87–96%) and 94% (range 87–96%) for entering respectively the itch and pain score. Daily symptom scores provided good insights into the disease burden, and patients rated the e‐diary as good to excellent with respect to user acceptability. CONCLUSIONS: The results suggest that the e‐diary is an excellent way to ensure proper treatment administration, indicated by both the high user acceptability scores and high treatment adherence. Moreover, the e‐diary may also be valuable for frequent and reliable monitoring of patient‐reported outcomes in daily clinical practice. John Wiley and Sons Inc. 2019-09-04 2020-03 /pmc/articles/PMC7064941/ /pubmed/31419338 http://dx.doi.org/10.1111/jdv.15872 Text en © 2019 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Teledermatology Rijsbergen, M. Niemeyer‐van der Kolk, T. Rijneveld, R. Pinckaers, J.H.F.M. Meshcheriakov, I. Bouwes Bavinck, J.N. van Doorn, M.B.A. Hogendoorn, G. Feiss, G. Cohen, A.F. Burggraaf, J. van Poelgeest, M.I.E. Rissmann, R. Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology |
title | Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology |
title_full | Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology |
title_fullStr | Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology |
title_full_unstemmed | Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology |
title_short | Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology |
title_sort | mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology |
topic | Teledermatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064941/ https://www.ncbi.nlm.nih.gov/pubmed/31419338 http://dx.doi.org/10.1111/jdv.15872 |
work_keys_str_mv | AT rijsbergenm mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology AT niemeyervanderkolkt mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology AT rijneveldr mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology AT pinckaersjhfm mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology AT meshcheriakovi mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology AT bouwesbavinckjn mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology AT vandoornmba mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology AT hogendoorng mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology AT feissg mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology AT cohenaf mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology AT burggraafj mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology AT vanpoelgeestmie mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology AT rissmannr mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology |